Time on boards
- Boards served
- 3
- Current seats
- 3
- Board service
- 9 years
- Director since
- 2023
9 years of board service in total across 3 boards, counting each seat separately. Longest: Edwards Lifesciences Corporation, 3 years.
Edwards Lifesciences Corporation
Director
Public Storage
Director
Ingram Micro Holding Corporation
Director
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| May 14, 2026 | Ingram Micro Holding Corporation | Grant or award | +7,031 | — | — |
| May 8, 2026 | Edwards Lifesciences Corporation | Grant or award | +3,251 | — | — |
| Dec 12, 2025 | Edwards Lifesciences Corporation | Open-market sale | −2,615 | $83.41 | $218,117 |
| Jun 4, 2025 | Ingram Micro Holding Corporation | Grant or award | +9,615 | — | — |
| May 9, 2025 | Edwards Lifesciences Corporation | Grant or award | +3,528 | — | — |
| Feb 13, 2025 | Edwards Lifesciences Corporation | Option exercise | +5,739 | $45.32 | $260,091 |
| Feb 13, 2025 | Edwards Lifesciences Corporation | Open-market sale | −5,739 | $75.86 | $435,361 |
| Oct 23, 2024 | Ingram Micro Holding Corporation | Grant or award | +8,409 | — | — |
| May 8, 2024 | Edwards Lifesciences Corporation | Grant or award | +3,055 | — | — |
| Feb 8, 2024 | Edwards Lifesciences Corporation | Option exercise | +7,056 | $36.86 | $260,084 |
| Feb 8, 2024 | Edwards Lifesciences Corporation | Open-market sale | −7,056 | $86.45 | $609,991 |
| Aug 10, 2023 | Edwards Lifesciences Corporation | Open-market sale | −3,303 | $78.87 | $260,508 |
| May 12, 2023 | Edwards Lifesciences Corporation | Grant or award | +2,803 | — | — |
| Feb 16, 2023 | Edwards Lifesciences Corporation | Option exercise | +9,671 | $35.68 | $345,061 |
| Feb 16, 2023 | Edwards Lifesciences Corporation | Open-market sale | −9,671 | $76.82 | $742,926 |
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.